152 related articles for article (PubMed ID: 18363910)
1. Haptoglobin from psoriatic patients exhibits decreased activity in binding haemoglobin and inhibiting lecithin-cholesterol acyltransferase activity.
Cigliano L; Maresca B; Salvatore A; Nino M; Monfrecola G; Ayala F; Carlucci A; Pugliese RC; Pedone C; Abrescia P
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):417-25. PubMed ID: 18363910
[TBL] [Abstract][Full Text] [Related]
2. Haptoglobin binds the antiatherogenic protein apolipoprotein E - impairment of apolipoprotein E stimulation of both lecithin:cholesterol acyltransferase activity and cholesterol uptake by hepatocytes.
Cigliano L; Pugliese CR; Spagnuolo MS; Palumbo R; Abrescia P
FEBS J; 2009 Nov; 276(21):6158-71. PubMed ID: 19758344
[TBL] [Abstract][Full Text] [Related]
3. Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase.
Salvatore A; Cigliano L; Bucci EM; Corpillo D; Velasco S; Carlucci A; Pedone C; Abrescia P
Biochemistry; 2007 Oct; 46(39):11158-68. PubMed ID: 17824618
[TBL] [Abstract][Full Text] [Related]
4. Haptoglobin inhibits lecithin-cholesterol acyltransferase in human ovarian follicular fluid.
Balestrieri M; Cigliano L; Simone ML; Dale B; Abrescia P
Mol Reprod Dev; 2001 Jun; 59(2):186-91. PubMed ID: 11389553
[TBL] [Abstract][Full Text] [Related]
5. Identification of plasma haptoglobin forms which loosely bind hemoglobin.
Spagnuolo MS; Cigliano L; Maresca B; Pugliese CR; Abrescia P
Biol Chem; 2011 Apr; 392(4):371-6. PubMed ID: 21294680
[TBL] [Abstract][Full Text] [Related]
6. Haptoglobin binds apolipoprotein E and influences cholesterol esterification in the cerebrospinal fluid.
Salvatore A; Cigliano L; Carlucci A; Bucci EM; Abrescia P
J Neurochem; 2009 Jul; 110(1):255-63. PubMed ID: 19457062
[TBL] [Abstract][Full Text] [Related]
7. Assignment of the binding site for haptoglobin on apolipoprotein A-I.
Spagnuolo MS; Cigliano L; D'Andrea LD; Pedone C; Abrescia P
J Biol Chem; 2005 Jan; 280(2):1193-8. PubMed ID: 15533931
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the haptoglobin binding region on the apolipoprotein A-I-derived P2a peptide.
Spagnuolo MS; Di Stasi R; De Rosa L; Maresca B; Cigliano L; D'Andrea LD
J Pept Sci; 2013 Apr; 19(4):220-6. PubMed ID: 23420675
[TBL] [Abstract][Full Text] [Related]
9. Relevance of the amino acid conversions L144R (Zaragoza) and L159P (Zavalla) in the apolipoprotein A-I binding site for haptoglobin.
Cigliano L; D'Andrea LD; Maresca B; Serino M; Carlucci A; Salvatore A; Spagnuolo MS; Scigliuolo G; Pedone C; Abrescia P
Biol Chem; 2008 Nov; 389(11):1421-6. PubMed ID: 18783334
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein A-I (ApoA-I) mimetic peptide P2a by restoring cholesterol esterification unmasks ApoA-I anti-inflammatory endogenous activity in vivo.
Bucci M; Cigliano L; Vellecco V; D'Andrea LD; Ziaco B; Rossi A; Sautebin L; Carlucci A; Abrescia P; Pedone C; Ianaro A; Cirino G
J Pharmacol Exp Ther; 2012 Mar; 340(3):716-22. PubMed ID: 22171091
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A-I-dependent cholesterol esterification in patients with rheumatoid arthritis.
Cigliano L; Spagnuolo MS; Cuomo G; Valentini G; Niglio A; Abrescia P
Life Sci; 2005 May; 77(1):108-20. PubMed ID: 15848223
[TBL] [Abstract][Full Text] [Related]
12. The binding of haptoglobin to apolipoprotein AI: influence of hemoglobin and concanavalin A.
Spagnuolo MS; Cigliano L; Abrescia P
Biol Chem; 2003 Dec; 384(12):1593-6. PubMed ID: 14719801
[TBL] [Abstract][Full Text] [Related]
13. Probing the 121-136 domain of lecithin:cholesterol acyltransferase using antibodies.
Murray KR; Nair MP; Ayyobi AF; Hill JS; Pritchard PH; Lacko AG
Arch Biochem Biophys; 2001 Jan; 385(2):267-75. PubMed ID: 11368007
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of Apolipoprotein A1 and Lecithin:Cholesterol Acyltransferase in type 2 diabetes mellitus: Correlations with haptoglobin phenotypes.
Awadallah S; Madkour M; Hamidi RA; Alwafa EA; Hattab M; Zakkour B; Al-Matroushi A; Ahmed E; Al-Kitbi M
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S543-S546. PubMed ID: 28416369
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A-I helix 6 negatively charged residues attenuate lecithin-cholesterol acyltransferase (LCAT) reactivity.
Alexander ET; Bhat S; Thomas MJ; Weinberg RB; Cook VR; Bharadwaj MS; Sorci-Thomas M
Biochemistry; 2005 Apr; 44(14):5409-19. PubMed ID: 15807534
[TBL] [Abstract][Full Text] [Related]
16. [Gas-chromatographic method for determination of plasma lecithin-cholesterol acyl transferase (LCAT) activity].
Ciampi G; Messeri G
Quad Sclavo Diagn; 1974 Dec; 10(4):536-49. PubMed ID: 4460077
[TBL] [Abstract][Full Text] [Related]
17. [Lecithin-cholesterol-acyltransferase activity in chronic liver diseases].
Gaskina TK; Dolgov AV; Kurilovich SA
Vopr Med Khim; 1987; 33(4):96-9. PubMed ID: 3660750
[TBL] [Abstract][Full Text] [Related]
18. Differential utilization by Haemophilus influenzae of haemoglobin complexed to the three human haptoglobin phenotypes.
Morton DJ; VanWagoner TM; Seale TW; Whitby PW; Stull TL
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):426-32. PubMed ID: 16553817
[TBL] [Abstract][Full Text] [Related]
19. Utilization of haem from the haptoglobin-haemoglobin complex by Bacteroides fragilis.
Otto BR; Sparrius M; Wors DJ; de Graaf FK; MacLaren DM
Microb Pathog; 1994 Sep; 17(3):137-47. PubMed ID: 7700131
[TBL] [Abstract][Full Text] [Related]
20. A dual role for lecithin:cholesterol acyltransferase (EC 2.3.1.43) in lipoprotein oxidation.
McPherson PA; Young IS; McEneny J
Free Radic Biol Med; 2007 Dec; 43(11):1484-93. PubMed ID: 17964419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
